Astrana 医疗

最新新闻

• 评级变动
  Jefferies Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $53
  \u5e02\u573a\u8d44\u8baf · 2026/6/30
• 评级变动
  TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 公司公告
  Apollo Medical: Apollo Medical Holdings, Inc. - Name/Symbol Change Option Symbol: AMEH New Symbol: ASTH
  OCC · 2024/2/24
• 公司公告
  Apollo Medical: Apollo Medical Holdings, Inc. - Name/Symbol Change Option Symbol: AMEH New Symbol: ASTH
  OCC · 2024/2/24
• 评级变动
  Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/5/19
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)
  TipRanks · 2026/7/14
• 评级变动
  BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• Barclays Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $53
  \u5e02\u573a\u8d44\u8baf · 2026/8/28
• 评级变动
  Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Barclays Upgrades Astrana Health(ASTH.US) to Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/5/26
• Freedom Capital Markets Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: Astrana Health (ASTH), ArriVent BioPharma, Inc. (AVBP)
  TipRanks · 2026/7/14
• 评级变动
  A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53
  \u5e02\u573a\u8d44\u8baf · 2026/8/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。